CVE-2025-48135: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in aptivadadev Aptivada for WP
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in aptivadadev Aptivada for WP allows DOM-Based XSS. This issue affects Aptivada for WP: from n/a through 2.0.0.
AI Analysis
Technical Summary
CVE-2025-48135 is a Cross-site Scripting (XSS) vulnerability classified under CWE-79, affecting the Aptivada for WP plugin developed by aptivadadev. This vulnerability arises from improper neutralization of input during web page generation, specifically enabling DOM-based XSS attacks. DOM-based XSS occurs when client-side scripts write user-controllable data to the Document Object Model (DOM) without proper sanitization or encoding, allowing attackers to execute arbitrary JavaScript in the context of the victim's browser. The affected product versions include Aptivada for WP up to version 2.0.0, with no earlier versions explicitly excluded. The vulnerability has a CVSS 3.1 base score of 6.5, indicating a medium severity level. The vector string CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L reveals that the attack can be launched remotely over the network with low attack complexity, requires low privileges, and user interaction is necessary. The scope is changed, meaning the vulnerability affects resources beyond the initially vulnerable component. The impact includes low confidentiality, integrity, and availability losses, consistent with typical XSS consequences such as session hijacking, defacement, or redirection to malicious sites. No known exploits are currently reported in the wild, and no patches or fixes have been linked yet. The vulnerability was published on May 16, 2025, and is enriched by CISA, indicating recognition by authoritative cybersecurity entities. Overall, this vulnerability allows an attacker to inject malicious scripts into web pages generated by Aptivada for WP, potentially compromising user sessions and data confidentiality through client-side exploitation.
Potential Impact
For European organizations using WordPress sites with the Aptivada for WP plugin, this vulnerability poses a tangible risk to web application security and user trust. Exploitation could lead to theft of session cookies, enabling account takeover or unauthorized actions within the affected web application. This can result in data leakage, defacement of public-facing websites, or redirection of users to phishing or malware distribution sites. Given the medium severity and requirement for user interaction, the threat is more pronounced for sites with high user engagement or sensitive user data. The scope change in the CVSS vector suggests that exploitation could affect other components or users beyond the initial plugin context, potentially amplifying damage. European organizations in sectors such as e-commerce, finance, healthcare, and public services that rely on WordPress and this plugin may face reputational damage, regulatory scrutiny under GDPR for data breaches, and operational disruptions. The absence of known exploits in the wild currently reduces immediate risk but does not eliminate the potential for future attacks, especially as threat actors often weaponize such vulnerabilities once disclosed.
Mitigation Recommendations
Organizations should immediately audit their WordPress installations to identify the presence of the Aptivada for WP plugin and verify its version. Until an official patch is released, administrators should consider disabling or removing the plugin to eliminate exposure. Web application firewalls (WAFs) can be configured with custom rules to detect and block typical XSS payloads targeting this vulnerability. Implementing Content Security Policy (CSP) headers can mitigate the impact of injected scripts by restricting script execution sources. Developers and site administrators should review and sanitize all user inputs and outputs related to the plugin, applying strict encoding and validation on both client and server sides. Monitoring web traffic and logs for unusual script injections or user complaints about suspicious behavior can provide early detection. Once a patch becomes available, prompt application of updates is critical. Additionally, educating users about the risks of interacting with suspicious links can reduce the likelihood of successful exploitation requiring user interaction.
Affected Countries
Germany, France, United Kingdom, Netherlands, Italy, Spain, Poland, Sweden
CVE-2025-48135: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in aptivadadev Aptivada for WP
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in aptivadadev Aptivada for WP allows DOM-Based XSS. This issue affects Aptivada for WP: from n/a through 2.0.0.
AI-Powered Analysis
Technical Analysis
CVE-2025-48135 is a Cross-site Scripting (XSS) vulnerability classified under CWE-79, affecting the Aptivada for WP plugin developed by aptivadadev. This vulnerability arises from improper neutralization of input during web page generation, specifically enabling DOM-based XSS attacks. DOM-based XSS occurs when client-side scripts write user-controllable data to the Document Object Model (DOM) without proper sanitization or encoding, allowing attackers to execute arbitrary JavaScript in the context of the victim's browser. The affected product versions include Aptivada for WP up to version 2.0.0, with no earlier versions explicitly excluded. The vulnerability has a CVSS 3.1 base score of 6.5, indicating a medium severity level. The vector string CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L reveals that the attack can be launched remotely over the network with low attack complexity, requires low privileges, and user interaction is necessary. The scope is changed, meaning the vulnerability affects resources beyond the initially vulnerable component. The impact includes low confidentiality, integrity, and availability losses, consistent with typical XSS consequences such as session hijacking, defacement, or redirection to malicious sites. No known exploits are currently reported in the wild, and no patches or fixes have been linked yet. The vulnerability was published on May 16, 2025, and is enriched by CISA, indicating recognition by authoritative cybersecurity entities. Overall, this vulnerability allows an attacker to inject malicious scripts into web pages generated by Aptivada for WP, potentially compromising user sessions and data confidentiality through client-side exploitation.
Potential Impact
For European organizations using WordPress sites with the Aptivada for WP plugin, this vulnerability poses a tangible risk to web application security and user trust. Exploitation could lead to theft of session cookies, enabling account takeover or unauthorized actions within the affected web application. This can result in data leakage, defacement of public-facing websites, or redirection of users to phishing or malware distribution sites. Given the medium severity and requirement for user interaction, the threat is more pronounced for sites with high user engagement or sensitive user data. The scope change in the CVSS vector suggests that exploitation could affect other components or users beyond the initial plugin context, potentially amplifying damage. European organizations in sectors such as e-commerce, finance, healthcare, and public services that rely on WordPress and this plugin may face reputational damage, regulatory scrutiny under GDPR for data breaches, and operational disruptions. The absence of known exploits in the wild currently reduces immediate risk but does not eliminate the potential for future attacks, especially as threat actors often weaponize such vulnerabilities once disclosed.
Mitigation Recommendations
Organizations should immediately audit their WordPress installations to identify the presence of the Aptivada for WP plugin and verify its version. Until an official patch is released, administrators should consider disabling or removing the plugin to eliminate exposure. Web application firewalls (WAFs) can be configured with custom rules to detect and block typical XSS payloads targeting this vulnerability. Implementing Content Security Policy (CSP) headers can mitigate the impact of injected scripts by restricting script execution sources. Developers and site administrators should review and sanitize all user inputs and outputs related to the plugin, applying strict encoding and validation on both client and server sides. Monitoring web traffic and logs for unusual script injections or user complaints about suspicious behavior can provide early detection. Once a patch becomes available, prompt application of updates is critical. Additionally, educating users about the risks of interacting with suspicious links can reduce the likelihood of successful exploitation requiring user interaction.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- Patchstack
- Date Reserved
- 2025-05-15T18:01:40.431Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682cd0f91484d88663aebd6e
Added to database: 5/20/2025, 6:59:05 PM
Last enriched: 7/11/2025, 11:03:19 PM
Last updated: 8/16/2025, 7:17:45 PM
Views: 9
Related Threats
CVE-2025-53948: CWE-415 Double Free in Santesoft Sante PACS Server
HighCVE-2025-52584: CWE-122 Heap-based Buffer Overflow in Ashlar-Vellum Cobalt
HighCVE-2025-46269: CWE-122 Heap-based Buffer Overflow in Ashlar-Vellum Cobalt
HighCVE-2025-54862: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Santesoft Sante PACS Server
MediumCVE-2025-54759: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Santesoft Sante PACS Server
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.